Three-pronged approach could cut new HIV infections by nearly 50% in the UK by 2020

Pre-exposure prophylactic drugs could help reverse HIV epidemic among men who have sex with men

Antiretroviral therapy (ART) taken as pre-exposure prophylaxis (PrEP) could help dramatically reduce the new HIV infection rate among men who have sex with men (MSM), according to a new study published in The Lancet HIV.

Research led by the London School of Hygiene & Tropical Medicine examined the effectiveness of PrEP used alongside regular HIV testing and early treatment. They found that offering this three-pronged approach to just a quarter of MSM at high risk of contracting HIV could prevent around 7,400 new HIV infections (44% of total incidence) in the UK by 2020.

PrEP is an HIV prevention strategy in which people at high risk of becoming exposed to HIV take antiretroviral drugs to reduce their chance of becoming infected. The medication helps to prevent the virus from establishing itself and multiplying in the body.

In this study a mathematical model was fitted with behavioural and surveillance data to evaluate the ability of various HIV prevention measures including expansion of HIV testing, test-and-treat programmes, PrEP, and sexual behavioural changes, to prevent HIV infections in MSM (aged 15 to 64 years old) in the UK between 2014 and 2020. If the status quo is maintained, the researchers predict 16,955 new HIV infections in MSM between 2014 and 2020.


The researchers estimate that even when targeted only at high-risk men, PrEP was more effective than all other individual measures aimed at the entire UK MSM population, preventing 59% of new infections (9,955). However, they predict that the greatest number of infections would be prevented by a 'practical combined prevention programme' that includes PrEP alongside yearly HIV testing for HIV-negative men and immediate ART for HIV-positive men.

Dr Narat Punyacharoensin who conducted the research while at the London School of Hygiene & Tropical Medicine, said: "Current prevention efforts in the UK that focus on correct and consistent condom use and regular HIV testing have been falling short. HIV rates among men who have sex with men remain high with around 2,800 men who have sex with men becoming infected with HIV in 2014, and the trend shows no sign of abating. Our results show that pre-exposure prophylaxis offers a major opportunity to curb new infections and could help reverse the HIV epidemic among men who have sex with men in the UK."

One of the main concerns about PrEP is whether men who know they are protected by prophylaxis will compensate for this by increasing their sexual risk-taking, for example by increasing their levels of unprotected sex (risk compensation). In this study, risk-compensation analyses indicate that even a substantial increase in unprotected anal intercourse and sexual partners is unlikely to completely counteract the strong HIV prevention benefit of prophylaxis.

Professor Noel Gill, Head of Public Health England's HIV and STI Department and a co-author, said: "The findings imply that a pre-exposure prophylaxis programme could be an important addition to current efforts to prevent HIV transmission in England. Public Health England has provided much evidence to NHS England to help inform their decision analysis process. This evidence includes studies on the cost-effectiveness, the budgetary impact, and public health impact of a possible publically funded HIV pre-exposure prophylaxis policy."


Narat Punyacharoensin, William John Edmunds, Daniela De Angelis, Valerie Delpech, Graham Hart, Jonathan Elford, Alison Brown, Noel Gill, Richard Guy White. Effect of pre-exposure prophylaxis and combination HIV prevention for men who have sex with men in the UK: a mathematical modelling study. The Lancet HIV.  DOI: 10.1016/S2352-3018(15)00056-9

COVID-19 Response Fund

There cannot be any complacency as to the need for global action.

With your help, we can plug critical gaps in the understanding of COVID-19. This will support global response efforts and help to save lives around the world.